메뉴 건너뛰기




Volumn 7, Issue , 2008, Pages

Therapeutic and prophylactic effect of intermittent preventive anti-malarial treatment in infants (IPTi) from Ghana and Gabon

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTESUNATE; FANSIDAR; PLACEBO; ANTIMALARIAL AGENT; PYRIMETHAMINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE; UNCLASSIFIED DRUG;

EID: 56649089812     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-7-198     Document Type: Article
Times cited : (20)

References (32)
  • 1
    • 15044338866 scopus 로고    scopus 로고
    • The global distribution of clinical episodes of Plasmodium falciparum malaria
    • 10.1038/nature03342
    • The global distribution of clinical episodes of Plasmodium falciparum malaria. RW Snow CA Guerra AM Noor HY Myint H SI, Nature 2005 434 209 217 10.1038/nature03342
    • (2005) Nature , vol.434 , pp. 209-217
    • Snow, R.W.1    Guerra, C.A.2    Noor, A.M.3    Myint, H.Y.4    Si, H.5
  • 2
    • 3843070027 scopus 로고    scopus 로고
    • Insecticide-treated bed nets and curtains for preventing malaria
    • 15106149
    • Insecticide-treated bed nets and curtains for preventing malaria. C Lengeler, Cochrane Database Syst Rev 2004 CD000363 15106149
    • (2004) Cochrane Database Syst Rev , pp. 000363
    • Lengeler, C.1
  • 3
    • 4344577124 scopus 로고    scopus 로고
    • Conquering the intolerable burden of malaria: What's new, what's needed: A summary
    • 15331814
    • Conquering the intolerable burden of malaria: what's new, what's needed: a summary. JG Breman MS Alilio A Mills, Am J Trop Med Hyg 2004 71 2 Suppl 1 15 15331814
    • (2004) Am J Trop Med Hyg , vol.71 , Issue.2 SUPPL. , pp. 1-15
    • Breman, J.G.1    Alilio, M.S.2    Mills, A.3
  • 4
    • 0242716179 scopus 로고    scopus 로고
    • Chemoresistance in falciparum malaria
    • discussion 435-436. 10.1016/j.pt.2003.08.001. 14519577
    • Chemoresistance in falciparum malaria. J May CG Meyer, Trends Parasitol 2003 19 432 435 discussion 435-436 10.1016/j.pt.2003.08.001 14519577
    • (2003) Trends Parasitol , vol.19 , pp. 432-435
    • May, J.1    Meyer, C.G.2
  • 6
    • 35848931645 scopus 로고    scopus 로고
    • Intermittent preventive therapy for malaria: Progress and future directions
    • 17975412
    • Intermittent preventive therapy for malaria: progress and future directions. MP Grobusch A Egan RD Gosling RD Newman, Curr Opin Infect Dis 2007 20 6 613 620 17975412
    • (2007) Curr Opin Infect Dis , vol.20 , Issue.6 , pp. 613-620
    • Grobusch, M.P.1    Egan, A.2    Gosling, R.D.3    Newman, R.D.4
  • 7
    • 24144482809 scopus 로고    scopus 로고
    • The promise and potential challenges of intermittent preventive treatment for malaria in infants (IPTi)
    • 16033653. 10.1186/1475-2875-4-33
    • The promise and potential challenges of intermittent preventive treatment for malaria in infants (IPTi). WP O'Meara JG Breman FE McKenzie, Malar J 2005 4 33 16033653 10.1186/1475-2875-4-33
    • (2005) Malar J , vol.4 , pp. 33
    • O'Meara, W.P.1    Breman, J.G.2    McKenzie, F.E.3
  • 9
    • 0035849308 scopus 로고    scopus 로고
    • Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: A randomised, placebo-controlled trial
    • 10.1016/S0140-6736(00)04643-2. 11377597
    • Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. D Schellenberg C Menendez E Kahigwa J Aponte J Vidal M Tanner H Mshinda P Alonso, Lancet 2001 357 1471 1477 10.1016/S0140-6736(00)04643-2 11377597
    • (2001) Lancet , vol.357 , pp. 1471-1477
    • Schellenberg, D.1    Menendez, C.2    Kahigwa, E.3    Aponte, J.4    Vidal, J.5    Tanner, M.6    Mshinda, H.7    Alonso, P.8
  • 12
    • 33746380284 scopus 로고    scopus 로고
    • Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: A randomized, placebo-controlled trial
    • 10.1086/505431. 16826474
    • Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial. E Macete P Aide JJ Aponte S Sanz I Mandomando M Espasa B Sigauque C Dobano S Mabunda M DgeDge P Alonso C Menendez, J Infect Dis 2006 194 276 285 10.1086/505431 16826474
    • (2006) J Infect Dis , vol.194 , pp. 276-285
    • MacEte, E.1    Aide, P.2    Aponte, J.J.3    Sanz, S.4    Mandomando, I.5    Espasa, M.6    Sigauque, B.7    Dobano, C.8    Mabunda, S.9    Dgedge, M.10    Alonso, P.11    Menendez, C.12
  • 15
    • 1942468860 scopus 로고    scopus 로고
    • Malaria intermittent preventive treatment in infants, chemoprophylaxis, and childhood vaccinations
    • 10.1016/S0140-6736(04)16052-2. 15110499
    • Malaria intermittent preventive treatment in infants, chemoprophylaxis, and childhood vaccinations. JB Rosen JG Breman, Lancet 2004 363 1386 1388 10.1016/S0140-6736(04)16052-2 15110499
    • (2004) Lancet , vol.363 , pp. 1386-1388
    • Rosen, J.B.1    Breman, J.G.2
  • 17
    • 14744276811 scopus 로고    scopus 로고
    • High prevalence of markers for sulfadoxine and pyrimethamine resistance in Plasmodium falciparum in the absence of drug pressure in the Ashanti Region of Ghana
    • 15728909. 10.1128/AAC.49.3.1101-1105.2005
    • High prevalence of markers for sulfadoxine and pyrimethamine resistance in Plasmodium falciparum in the absence of drug pressure in the Ashanti Region of Ghana. F Marks JA Evans CG Meyer EN Browne C Flessner V von Kalckreuth TA Eggelte RD Horstmann J May, Antimicrob Agents Chemother 2005 49 1101 1105 15728909 10.1128/AAC.49.3.1101-1105.2005
    • (2005) Antimicrob Agents Chemother , vol.49 , pp. 1101-1105
    • Marks, F.1    Evans, J.A.2    Meyer, C.G.3    Browne, E.N.4    Flessner, C.5    Von Kalckreuth, V.6    Eggelte, T.A.7    Horstmann, R.D.8    May, J.9
  • 22
    • 0030813699 scopus 로고    scopus 로고
    • The efficacy of antifolate antimalarial combinations in Africa: A predictive model based on pharmacodynamic and pharmacokinetic analyses
    • 10.1016/S0169-4758(97)01124-1. 15275132
    • The efficacy of antifolate antimalarial combinations in Africa: A predictive model based on pharmacodynamic and pharmacokinetic analyses. WM Watkins EK Mberu PA Winstanley CV Plowe, Parasitol Today 1997 13 459 464 10.1016/S0169-4758(97)01124-1 15275132
    • (1997) Parasitol Today , vol.13 , pp. 459-464
    • Watkins, W.M.1    Mberu, E.K.2    Winstanley, P.A.3    Plowe, C.V.4
  • 23
    • 0033119699 scopus 로고    scopus 로고
    • More on 'the efficacy of antifolate antimalarial combinations in Africa'
    • 10.1016/S0169-4758(99)01419-2. 10322331
    • More on 'the efficacy of antifolate antimalarial combinations in Africa'. WM Watkins EK Mberu PA Winstanley CV Plowe, Parasitol Today 1999 15 131 132 10.1016/S0169-4758(99)01419-2 10322331
    • (1999) Parasitol Today , vol.15 , pp. 131-132
    • Watkins, W.M.1    Mberu, E.K.2    Winstanley, P.A.3    Plowe, C.V.4
  • 24
    • 40149110041 scopus 로고    scopus 로고
    • How antimalarial drug resistance affects post treatment prophylaxis
    • 18186948. 10.1186/1475-2875-7-9
    • How antimalarial drug resistance affects post treatment prophylaxis. NJ White, Malar J 2008 7 9 18186948 10.1186/1475-2875-7-9
    • (2008) Malar J , vol.7 , pp. 9
    • White, N.J.1
  • 25
    • 17844402000 scopus 로고    scopus 로고
    • Intermittent preventive antimalarial treatment for Tanzanian infants: Follow-up to age 2 years of a randomised, placebo-controlled trial
    • 10.1016/S0140-6736(05)66418-5. 15850632
    • Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised, placebo-controlled trial. D Schellenberg C Menendez JJ Aponte E Kahigwa M Tanner H Mshinda P Alonso, Lancet 2005 365 1481 1483 10.1016/S0140-6736(05)66418-5 15850632
    • (2005) Lancet , vol.365 , pp. 1481-1483
    • Schellenberg, D.1    Menendez, C.2    Aponte, J.J.3    Kahigwa, E.4    Tanner, M.5    Mshinda, H.6    Alonso, P.7
  • 27
    • 0038730920 scopus 로고    scopus 로고
    • Effect of intermittent treatment with amodiaquine on anaemia and malarial fevers in infants in Tanzania: A randomised placebo-controlled trial
    • 10.1016/S0140-6736(03)13504-0. 12788572
    • Effect of intermittent treatment with amodiaquine on anaemia and malarial fevers in infants in Tanzania: a randomised placebo-controlled trial. JJ Massaga AY Kitua MM Lemnge JA Akida LN Malle AM Ronn TG Theander IC Bygbjerg, Lancet 2003 361 1853 1860 10.1016/S0140-6736(03)13504-0 12788572
    • (2003) Lancet , vol.361 , pp. 1853-1860
    • Massaga, J.J.1    Kitua, A.Y.2    Lemnge, M.M.3    Akida, J.A.4    Malle, L.N.5    Ronn, A.M.6    Theander, T.G.7    Bygbjerg, I.C.8
  • 29
    • 35448996140 scopus 로고    scopus 로고
    • Immune responses after single-dose sulphadoxine-pyrimethamine indicate underestimation of protective efficacy of intermittent preventive treatment in infants
    • 17956497
    • Immune responses after single-dose sulphadoxine-pyrimethamine indicate underestimation of protective efficacy of intermittent preventive treatment in infants. N Schreiber R Kobbe S Adjei O Adhei M-Q Klinkert J May, Trop Med Int Health 2007 12 1157 1163 17956497
    • (2007) Trop Med Int Health , vol.12 , pp. 1157-1163
    • Schreiber, N.1    Kobbe, R.2    Adjei, S.3    Adhei, O.4    Klinkert, M.-Q.5    May, J.6
  • 30
    • 3242692444 scopus 로고    scopus 로고
    • Antimalarial combinations
    • 10.1016/S0140-6736(04)16680-4. 15262108
    • Antimalarial combinations. PG Kremsner S Krishna, Lancet 2004 364 285 294 10.1016/S0140-6736(04)16680-4 15262108
    • (2004) Lancet , vol.364 , pp. 285-294
    • Kremsner, P.G.1    Krishna, S.2
  • 32
    • 48249132825 scopus 로고    scopus 로고
    • Duration of protection against malaria and anaemia provided by intermittent preventive treatment in infants in Navrongo, Ghana
    • 18493597. 10.1371/journal.pone.0002227
    • Duration of protection against malaria and anaemia provided by intermittent preventive treatment in infants in Navrongo, Ghana. M Cairns I Carneiro P Milligan S Owusu-Agyei T Awine R Gosling B Greenwood D Chandramohan, PLoS ONE 2008 3 e2227 18493597 10.1371/journal.pone.0002227
    • (2008) PLoS ONE , vol.3 , pp. 2227
    • Cairns, M.1    Carneiro, I.2    Milligan, P.3    Owusu-Agyei, S.4    Awine, T.5    Gosling, R.6    Greenwood, B.7    Chandramohan, D.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.